SHINE Technologies

United States
Marianne, Pennsylvania, United States, 53546

Company profile

SHINE Technologies company profile

SHINE deploys its safe, cost-effective, and environmentally friendly fusion technology in a stepwise approach. Its systems are used to inspect industrial components in aerospace, defense, energy, and other sectors. SHINE’s proprietary medical isotope production processes create molybdenum-99 and non-carrier-added lutetium-177. These important medicines are used in tens of thousands of daily procedures to diagnose and treat heart disease, late-stage cancer, and other serious illnesses. In the future, SHINE plans to scale its fusion technology to help solve one of the energy’s toughest hurdles by recycling nuclear waste. Through a purpose-driven and phased approach, SHINE aims to generate fusion power to deliver clean, abundant energy that could transform life on Earth.

Business identity

Contact email
[email protected]
Phone number
(608) 210-1060
Operating status
Active
Company type
For Profit
Employee range
251-500 employees
Revenue range
$1M-$10M
Founded
2005-01-01, Year

Headquarters

Postal code
53546
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
22
Total equity funding
$432.7M
Last funding
Series C / 2025-02-24
Last equity funding
Series C
Investors
14
Lead investors
10
Founders
2
Articles
87

Founders and investors

Founders

Gregory PieferGreg Piefer

Lead investors

ARPA-EBaillie GiffordDeerfieldFidelityGovernment of the NetherlandsKoch Disruptive TechnologiesNational Nuclear Security AdministrationNational Science FoundationOaktree Capital ManagementUS Department of Energy

Investors

Alumni VenturesDeerfieldFidelityNational Science FoundationOaktree Capital Management